Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.
2.

Emerging strategies for treating brain metastases from breast cancer.

Kodack DP, Askoxylakis V, Ferraro GB, Fukumura D, Jain RK.

Cancer Cell. 2015 Feb 9;27(2):163-75. doi: 10.1016/j.ccell.2015.01.001. Review.

PMID:
25670078
3.

New concepts in breast cancer genomics and genetics.

Goncalves R, Warner WA, Luo J, Ellis MJ.

Breast Cancer Res. 2014;16(5):460. Review.

4.

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.

Falahi F, van Kruchten M, Martinet N, Hospers GA, Rots MG.

Breast Cancer Res. 2014 Jul 29;16(4):412. doi: 10.1186/s13058-014-0412-z. Review.

5.

Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.

Luo L, Dong LY, Yan QG, Cao SJ, Wen XT, Huang Y, Huang XB, Wu R, Ma XP.

Asian Pac J Cancer Prev. 2014;15(20):8529-38. Review.

6.

From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer.

Fabris VT.

Cancer Genet. 2014 Jun;207(6):233-46. doi: 10.1016/j.cancergen.2014.06.025. Epub 2014 Jun 25. Review.

PMID:
25176624
7.

Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?

Guiu S, Wolfer A, Jacot W, Fumoleau P, Romieu G, Bonnetain F, Fiche M.

Crit Rev Oncol Hematol. 2014 Dec;92(3):235-57. doi: 10.1016/j.critrevonc.2014.07.003. Epub 2014 Jul 30. Review.

PMID:
25129506
8.

The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.

Ramon Y Cajal S, De Mattos-Arruda L, Sonenberg N, Cortes J, Peg V.

Clin Transl Oncol. 2014 Nov;16(11):937-41. doi: 10.1007/s12094-014-1203-9. Epub 2014 Jul 25. Review.

PMID:
25060567
9.

Genomic analysis of breast cancer heralds a changing treatment paradigm.

Ellis M.

J Natl Compr Canc Netw. 2014 May;12(5 Suppl):750-2. Review.

PMID:
24853210
10.

Molecular profiling of male breast cancer - lost in translation?

Johansson I, Killander F, Linderholm B, Hedenfalk I.

Int J Biochem Cell Biol. 2014 Aug;53:526-35. doi: 10.1016/j.biocel.2014.05.007. Epub 2014 May 16. Review.

11.

Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer.

Hoon DS, Bernet L, Cano R, Viale G.

Q J Nucl Med Mol Imaging. 2014 Jun;58(2):180-92. Review.

PMID:
24835292
12.

Proteomics for breast cancer urine biomarkers.

Beretov J, Wasinger VC, Graham PH, Millar EK, Kearsley JH, Li Y.

Adv Clin Chem. 2014;63:123-67. Review.

PMID:
24783353
13.

Management of women at high risk of breast cancer.

Armstrong AC, Evans GD.

BMJ. 2014 Apr 28;348:g2756. doi: 10.1136/bmj.g2756. Review. No abstract available.

PMID:
24778341
14.

First international consensus guidelines for breast cancer in young women (BCY1).

Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA Jr, Costa A, Delaloge S, Freilich G, Gentilini OD, Harbeck N, Kelly CM, Loibl S, Meirow D, Peccatori F, Kaufmann B, Cardoso F.

Breast. 2014 Jun;23(3):209-20. doi: 10.1016/j.breast.2014.03.011. Epub 2014 Apr 24.

PMID:
24767882
15.

Implications of functional proteomics in breast cancer.

Chae YK, Gonzalez-Angulo AM.

Oncologist. 2014 Apr;19(4):328-35. doi: 10.1634/theoncologist.2013-0437. Epub 2014 Mar 24. Review.

16.

Personalized therapy for breast cancer.

De Abreu FB, Schwartz GN, Wells WA, Tsongalis GJ.

Clin Genet. 2014 Jul;86(1):62-7. doi: 10.1111/cge.12381. Epub 2014 Apr 9. Review.

PMID:
24635704
17.

Genetic and epigenetic aspects of breast cancer progression and therapy.

Byler S, Goldgar S, Heerboth S, Leary M, Housman G, Moulton K, Sarkar S.

Anticancer Res. 2014 Mar;34(3):1071-7. Review.

PMID:
24596345
18.

Molecular tests as prognostic factors in breast cancer.

van de Vijver MJ.

Virchows Arch. 2014 Mar;464(3):283-91. doi: 10.1007/s00428-014-1539-0. Epub 2014 Feb 1. Review.

PMID:
24487789
19.

Breast cancer in 2013: Genomics, drug approval, and optimal treatment duration.

Lee AV, Davidson NE.

Nat Rev Clin Oncol. 2014 Feb;11(2):71-2. doi: 10.1038/nrclinonc.2013.250. Epub 2014 Jan 14. Review. No abstract available.

PMID:
24419301
20.

Adaptive reprogramming of the breast cancer kinome.

Stuhlmiller TJ, Earp HS, Johnson GL.

Clin Pharmacol Ther. 2014 Apr;95(4):413-5. doi: 10.1038/clpt.2014.8. Epub 2014 Jan 10. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk